EXPERIMENTAL RADIATION ONCOLOGY CONFERENCE
实验放射肿瘤学会议
基本信息
- 批准号:3434176
- 负责人:
- 金额:$ 0.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-08-01 至 1992-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Principle Investigator initiated this program on his appointment to the
Radiation Oncology Department of Oregon Health Sciences University with the
first "OHSU Experimental Radiation Oncology Conference" held on March 16th
and 17th 1989. His prior experience as the organizer of two similar
meetings at the University of Wisconsin, Madison in 1975 and 1981
contributed greatly to the success of the first Portland Conference. The
response by both the scientific and medical communities to this first
Oregon meeting (program enclosed demonstrated a need in Portland and the
Northwest for a forum which would provide an integrated approach to cancer-
related topics. The stimulus of the meeting and the recent initiation of
a radiobiology program on the OHSU campus has increased local interest and
awareness of experimental cancer studies. Continuing these "Experimental
Radiation Oncology Conferences" would further increase this interest and
awareness. Attendance at the 1989 Portland meeting was not only local. It
involved the medial and research communities state-wide and participants
both from out of state and from Europe and this provided an opportunity for
researchers from Portland (and the West Coast States generally) to exchange
ideas with invited speakers chosen for their innovative work. A number of
internationally recognized workers were able to attend the Portland
Conference as it had been scheduled as a satellite of the 1989 Radiation
Research meeting. Such a link will be retained to maximize the benefits
while keeping travel costs for invited speakers to an acceptable level.
Funds for the first conference were primarily provided by the "Clifford V.
Allen" fund set up to honor the first Chairman of the OHSU Radiation
Oncology Department on his retirement. This fund, and other limited local
resources, are now insufficient to support a further meeting. The present
grant request recognizes the need to continue these conferences and to
build on the success of the first meeting. The primary aim will be to
stimulate awareness among Oregon physicians and medial scientists of
developments in research fields which have potential therapeutic
implications. Each Conference will provide an integrated approach to the
topic chosen and it is anticipated that this will prove of particular
interest to local clinicians. The format of the meeting and the relatively
small number of participants (60-80) will maximize opportunities for
interactive discussion between the various participants.
The topic for the next meeting is "Intrinsic cellular sensitivity and
acquired resistance to radiation, heat and drugs". this is of clinical
importance and also the focus of substantial current research interest at
both the basic and the applied level. The topics for meetings in
subsequent years are "Biological bases of novel therapeutic approaches" and
"The role of molecular biology in cancer treatments".
首席研究员在他被任命为
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MILTON B YATVIN其他文献
MILTON B YATVIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MILTON B YATVIN', 18)}}的其他基金
USING LIPID LINKED AZT DRUGS TO IMPROVE HIV THERAPY
使用脂质连接的 AZT 药物改善 HIV 治疗
- 批准号:
2422870 - 财政年份:1997
- 资助金额:
$ 0.2万 - 项目类别: